During the past decade, Mission Dermatology Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mission Dermatology Center" are "Dominant Dystrophic Epidermolysis Bullosa" (3 trials), "Dystrophic Epidermolysis Bullosa" (3 trials), "Recessive Dystrophic Epidermolysis Bullosa" (3 trials) and "DEB - Dystrophic Epidermolysis Bullosa" (1 trials). Many other conditions were trialed in "Mission Dermatology Center" in a lesser frequency.

Most popular intervention types in "Mission Dermatology Center" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Open Label Topical Beremagene Geperpavec (B-VEC)" (1 trials), "Placebo" (1 trials) and "Topical Beremagene Geperpavec" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mission Dermatology Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mission Dermatology Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Mission Dermatology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mission Dermatology Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".